H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Percutaneous injection of chemotherapeutic drugs in the guidance of magnetic resonance imaging for the treatment of cholangiocarcinoma

Zhi-Hua Liu, Peng Zhang, Yu-Kun Zhou, Huan-Long Qin

Med Sci Monit 2010; 16(12): HY31-33

ID: 881278

Available online: 2010-11-30

Published: 2010-11-30


The morbidity and mortality of cholangiocarcinoma have been rising yearly. However, conventional therapies still cannot achieve a satisfactory survival rate. Furthermore, there is an urgent need to discover new approaches to overcome chemotherapeutic drug resistance of cholangiocarcinoma. Considering the unique advantage of magnetic irradiation, we hypothesize that percutaneous injection of chemotherapeutic drugs in the guidance of nuclear magnetic resonance imaging may enhance the survival rate of cholangiocarcinoma without increasing undesired side effects.

Keywords: Drug Delivery Systems - methods, Cholangiocarcinoma - drug therapy, Bile Ducts, Extrahepatic, Bile Duct Neoplasms - drug therapy, Administration, Cutaneous, Magnetic Resonance Imaging - methods



Back